During the past decade, St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 70 clinical trials were completed, i.e. on average, 538.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 16 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 29 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored, "Radiation Therapy Oncology Group" with 9 trials sponsored and "NSABP Foundation Inc" with 9 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 72 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center" are "Breast Cancer" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials), "Lung Cancer" (10 trials), "Lymphoma" (10 trials) and "Colorectal Cancer" (8 trials). Many other conditions were trialed in "St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center" in a lesser frequency.

Most popular intervention types in "St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center" are "Drug" (78 trials), "Other" (26 trials), "Biological" (22 trials), "Radiation" (19 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (15 trials), "Placebo" (11 trials), "cyclophosphamide" (10 trials), "bevacizumab" (8 trials) and "radiation therapy" (8 trials). Other intervention names were less common.

The vast majority of trials in "St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center" are 68 trials for "All" genders, 20 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center". undefined are not yet recruiting, undefined are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 73 completed trials in St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center, 3 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".